Inventor · Bethesda, MD, US

Christopher Breder

60Patents

21h-index

4Co-inventors

81Inventor score

Filing activity: Jul 18, 2002 → Aug 26, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7842307B2	Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent	Human Necessities	213	Expired
US7141250B2	Pharmaceutical formulation containing bittering agent	Human Necessities	209	Expired
US8337888B2	Pharmaceutical formulation containing gelling agent	Human Necessities	197	Active
US7144587B2	Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent	Human Necessities	194	Expired
US8389007B2	Pharmaceutical composition containing gelling agent	Human Necessities	95	Active
US8524275B2	Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent	Human Necessities	94	Active
US8609683B2	Pharmaceutical formulation containing gelling agent	Human Necessities	86	Active
US8529948B1	Pharmaceutical formulation containing gelling agent	Human Necessities	81	Active
US9060976B2	Pharmaceutical formulation containing gelling agent	Human Necessities	76	Active
US9044435B2	Pharmaceutical formulation containing gelling agent	Human Necessities	59	Active
US8871265B2	Pharmaceutical formulation containing gelling agent	Human Necessities	55	Active
US9034376B2	Pharmaceutical formulation containing gelling agent	Human Necessities	50	Active
US8465774B2	Sequestered antagonist formulations	Human Necessities	45	Active
US8999961B2	Pharmaceutical formulation containing gelling agent	Human Necessities	44	Active
US9040084B2	Pharmaceutical formulation containing gelling agent	Human Necessities	42	Active
US7914818B2	Opioid agonist formulations with releasable and sequestered antagonist	Human Necessities	40	Expired
US7943173B2	Pharmaceutical combinations of oxycodone and naloxone	Human Necessities	26	Expired
US9308171B2	Pharmaceutical formulation containing gelling agent	Human Necessities	25	Active
US9387173B2	Pharmaceutical formulation containing gelling agent	Human Necessities	25	Active
US9387174B2	Pharmaceutical formulation containing gelling agent	Human Necessities	25	Active
US9308170B2	Pharmaceutical formulation containing gelling agent	Human Necessities	24	Active
US8518443B2	Opioid agonist formulations with releasable and sequestered antagonist	Human Necessities	20	Active
US8231901B2	Opioid agonist formulations with releasable and sequestered antagonist	Human Necessities	18	Active
US9101668B2	Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent	Human Necessities	12	Active
US9693961B2	Pharmaceutical formulation containing gelling agent	Human Necessities	7	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.